Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase Ib multiple dose ascending trial of CPP 115 in volunteers.

Trial Profile

Phase Ib multiple dose ascending trial of CPP 115 in volunteers.

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 19 Sep 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs CPP 115 (Primary)
  • Indications Infantile spasms
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Sep 2016 According to a Catalyst Pharmaceutical media release, case study report of a patient from this study was accepted to be published in the journal of Epilepsy & Behavior Case Reports.
    • 19 Sep 2016 A case study report published in a Catalyst Pharmaceutical media release.
    • 16 Dec 2015 Top-line results published in a Catalyst Pharmaceutical media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top